Correlation Between Onxeo SA and Novo Nordisk
Can any of the company-specific risk be diversified away by investing in both Onxeo SA and Novo Nordisk at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Onxeo SA and Novo Nordisk into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Onxeo SA and Novo Nordisk AS, you can compare the effects of market volatilities on Onxeo SA and Novo Nordisk and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Onxeo SA with a short position of Novo Nordisk. Check out your portfolio center. Please also check ongoing floating volatility patterns of Onxeo SA and Novo Nordisk.
Diversification Opportunities for Onxeo SA and Novo Nordisk
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Onxeo and Novo is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Onxeo SA and Novo Nordisk AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novo Nordisk AS and Onxeo SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Onxeo SA are associated (or correlated) with Novo Nordisk. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novo Nordisk AS has no effect on the direction of Onxeo SA i.e., Onxeo SA and Novo Nordisk go up and down completely randomly.
Pair Corralation between Onxeo SA and Novo Nordisk
Assuming the 90 days horizon Onxeo SA is expected to under-perform the Novo Nordisk. In addition to that, Onxeo SA is 3.6 times more volatile than Novo Nordisk AS. It trades about 0.0 of its total potential returns per unit of risk. Novo Nordisk AS is currently generating about 0.06 per unit of volatility. If you would invest 9,740 in Novo Nordisk AS on September 22, 2024 and sell it today you would earn a total of 220.00 from holding Novo Nordisk AS or generate 2.26% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Onxeo SA vs. Novo Nordisk AS
Performance |
Timeline |
Onxeo SA |
Novo Nordisk AS |
Onxeo SA and Novo Nordisk Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Onxeo SA and Novo Nordisk
The main advantage of trading using opposite Onxeo SA and Novo Nordisk positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Onxeo SA position performs unexpectedly, Novo Nordisk can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Nordisk will offset losses from the drop in Novo Nordisk's long position.Onxeo SA vs. Novo Nordisk AS | Onxeo SA vs. CSL LTD SPONADR | Onxeo SA vs. CSL Limited | Onxeo SA vs. Mercedes Benz Group AG |
Novo Nordisk vs. CSL LTD SPONADR | Novo Nordisk vs. CSL Limited | Novo Nordisk vs. Mercedes Benz Group AG | Novo Nordisk vs. Vertex Pharmaceuticals Incorporated |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |